Clinical Operations Leadership Proposal Request
Request a Proposal from Choice ClinOps
Choice ClinOps welcomes clinical trials proposal requests from small- and mid-size global pharma, biopharma, and biotech sponsors seeking fractional leadership in clinical operations. Each proposal request is personally reviewed by founder and CEO Leila Cupersmith, a seasoned clinical operations executive with over 24 years of experience on both the sponsor and CRO sides across more than 30 countries. As a women-owned and minority-owned business, Choice ClinOps qualifies as a diverse supplier for sponsors with supplier diversity requirements.
Who Should Submit an RFP
Submit a clinical trials proposal if your organization is formally evaluating vendors for any of the following:
- Study rescue — restoring governance, alignment, and execution in a delayed, drifting, or over-budget clinical trial.
- Ensuring clinical operations continuity through disruption — mergers and acquisitions, CRO and vendor transitions, portfolio shifts, management change, and other significant company or study disruptions.
- Effective risk and change management.
- Conducting study and vendor audits with ready-to-execute remediation strategies.
- Governance of CROs, vendors, site networks, and patient advocacy groups.
- Site and vendor readiness, including audit readiness and activation.
- Portfolio and study governance.
- Providing fractional leadership through executive clinical operations embedded in a lean sponsor team.
Choice ClinOps supports first-in-human, Phase 1, and Phase 2 oncology, rare oncology, rare disease, and cell and gene therapy clinical trials across Canada, the United States, South and Latin America, EMEA, the United Kingdom, and APAC.
What We Will Need From You
To prepare a meaningful clinical trials proposal rather than a generic one, please be ready to share:
- Therapeutic area and indication — oncology, rare oncology, rare disease, or cell and gene therapy
- Trial phase — first-in-human, Phase 1, Phase 2, or a mixed portfolio
- Geography — the countries and regions where your study is running or will run
- Current state — is this a new study, an active study, a study at risk, or a program in transition?
- CRO and vendor landscape — who is engaged, and where oversight or accountability feels thin
- Scope of support sought — which of our areas of focus apply, considering options like fractional leadership
- Timeline — when support is needed and any fixed milestones or regulatory dates
- Decision process — who is involved, and your expected timeline to award
Attach a protocol synopsis, scope of work, or RFP document if you have one. Partial information is fine — we would rather begin the conversation about clinical operations than wait for a complete package.
What Happens After You Submit
Within two business days, Leila Cupersmith personally reviews your submission and responds directly regarding your clinical operations needs.
Within one week (5 business days from date of receipt), we schedule a scoping conversation with the senior executive who would lead your engagement — this is not a salesperson, but an expert in clinical trials proposal development.
Following that conversation, you will receive a written proposal that defines the scope, embedded roles, engagement model, and commercial terms for fractional leadership in your project.
If Choice ClinOps is not the right fit for your program, we will clearly communicate that and, where possible, direct you to someone better suited to your clinical operations requirements.
Confidentiality
Information submitted through this form regarding your clinical trials proposal is treated as confidential and reviewed solely by the leadership at Choice ClinOps. If your program requires a confidentiality agreement before discussing any clinical operations details, please email Leila@ChoiceClinOps.com, and we will execute a CDA before you submit anything further.
Why Sponsors Select Choice ClinOps
Not a CRO, not a staffing company, not a consulting firm. Choice ClinOps embeds senior clinical operations executives on the sponsor side, governing CROs and vendors rather than replacing them. We offer fractional leadership through a team of six fractional clinical operations executives, each with over 20 years of hands-on experience across sponsor, CRO, and site environments. With 24+ years of leadership experience in clinical trials, from first-in-human studies to Phase 3 trials in 30+ countries, we have successfully managed over 50 clinical trials with study budgets exceeding $137M, delivering significant six-figure cost avoidance. As a women-owned and minority-owned organization, founded and led by Leila Cupersmith, a Puerto Rican woman and clinical operations executive, Choice ClinOps qualifies as a diverse supplier for sponsors with supplier diversity requirements. We prioritize capacity discipline, declining work that we cannot deliver to our own high standards. Every client receives access to our senior team for the full duration of the engagement, ensuring expert guidance throughout each clinical trials proposal.
Submit Your Request for Proposal
Complete the form below to submit your clinical trials proposal request. Fields marked as required are essential for us to respond, while any additional information will help us prepare a sharper proposal, especially in the context of clinical operations or fractional leadership.
Alternative path
Prefer to discuss your clinical trials proposal before submitting a formal RFP? Book an Exploratory Discussion — a concise, senior-led assessment of how your clinical operations are performing and where execution may be exposed, leveraging our expertise in fractional leadership.